MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 66 filers reported holding MERSANA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,740,566 | -58.5% | 2,157,665 | +7.6% | 0.00% | -100.0% |
Q2 2023 | $6,598,693 | -10.7% | 2,005,682 | +11.5% | 0.00% | 0.0% |
Q1 2023 | $7,393,261 | +73795.7% | 1,798,847 | +5.4% | 0.00% | 0.0% |
Q4 2022 | $10,005 | -99.9% | 1,707,470 | +3.5% | 0.00% | -50.0% |
Q3 2022 | $11,154,000 | +53.6% | 1,650,019 | +5.0% | 0.00% | +100.0% |
Q2 2022 | $7,262,000 | +56.0% | 1,571,940 | +34.7% | 0.00% | 0.0% |
Q1 2022 | $4,655,000 | -34.2% | 1,166,807 | +2.6% | 0.00% | 0.0% |
Q4 2021 | $7,072,000 | -29.5% | 1,137,001 | +6.8% | 0.00% | 0.0% |
Q3 2021 | $10,036,000 | -29.7% | 1,064,335 | +1.2% | 0.00% | -50.0% |
Q2 2021 | $14,285,000 | -7.8% | 1,051,919 | +9.8% | 0.00% | 0.0% |
Q1 2021 | $15,501,000 | -32.2% | 958,051 | +11.5% | 0.00% | -50.0% |
Q4 2020 | $22,865,000 | +48.1% | 859,301 | +3.7% | 0.00% | +33.3% |
Q3 2020 | $15,435,000 | -13.3% | 828,976 | +8.9% | 0.00% | -25.0% |
Q2 2020 | $17,813,000 | +476.8% | 761,252 | +43.7% | 0.00% | +300.0% |
Q1 2020 | $3,088,000 | -49.1% | 529,788 | -49.9% | 0.00% | 0.0% |
Q4 2019 | $6,064,000 | +692.7% | 1,058,344 | +118.5% | 0.00% | – |
Q3 2019 | $765,000 | -60.9% | 484,412 | +0.2% | 0.00% | – |
Q2 2019 | $1,957,000 | +0.7% | 483,216 | +30.7% | 0.00% | -100.0% |
Q1 2019 | $1,944,000 | +85.9% | 369,661 | +44.1% | 0.00% | – |
Q4 2018 | $1,046,000 | -14.5% | 256,464 | +109.5% | 0.00% | – |
Q3 2018 | $1,224,000 | -24.6% | 122,434 | +34.7% | 0.00% | – |
Q2 2018 | $1,623,000 | +19.4% | 90,909 | +5.4% | 0.00% | – |
Q1 2018 | $1,359,000 | +31.1% | 86,217 | +36.5% | 0.00% | – |
Q4 2017 | $1,037,000 | +4.6% | 63,173 | +10.1% | 0.00% | – |
Q3 2017 | $991,000 | – | 57,352 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $40,026,000 | 4.69% |
Opaleye Management Inc. | 1,047,000 | $4,837,000 | 2.18% |
Sarissa Capital Management LP | 4,299,297 | $19,863,000 | 2.00% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $4,178,000 | 1.58% |
SILVERARC CAPITAL MANAGEMENT, LLC | 850,000 | $3,927,000 | 1.21% |
Orbimed Advisors | 9,011,437 | $41,633,000 | 0.75% |
Avoro Capital Advisors LLC | 7,550,000 | $34,881,000 | 0.69% |
Rock Springs Capital Management LP | 4,075,958 | $18,831,000 | 0.55% |
Artal Group S.A. | 2,200,000 | $10,164,000 | 0.54% |
DAFNA Capital Management LLC | 406,763 | $1,879,000 | 0.51% |